Thrombectomy Devices Market Analysis By Geography, Competitors, Trends and Demands To 2026

Thrombectomy refers to physical removal of soft thrombus. A thrombectomy device is easy to use and consistently opens blood vessels. Use of thrombectomy devices can improve long-term neurological outcomes by providing higher rates of procedural recanalization. Thrombectomy devices can be used in patients for whom pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate for instance, in case of recent surgery or in patients who are taking oral anticoagulants.

Get Exclusive Sample Copy @

According to the National Institute for Health and Care Excellence (NICE) 2018 report, the risk of stroke increases with age and the chances of getting stroke is higher in men and Asian people. Thrombectomy treatment provides an alternative in the absence of access to standard of care such as thrombolysis, which is contraindicated during pregnancy.

Rising demand for minimally invasive procedures coupled with increased patient population of stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE) are expected to drive growth of the thrombectomy devices market during the forecast period. According to WHO 2018 report, stroke is the second most common cause of death in the world, with 6.7 million stroke-related deaths each year. Moreover, the burden of disease caused by stroke is set to double worldwide, by 2030.

High cost of thrombectomy devices eventually increases its procedure cost, which is a major setback for surgery adoption. According to NICE, July 2018 data, the cost of mechanical thrombectomy devices ranges between US$ 700 to US$ 1,719 for aspiration catheters and US$ 1,911 to US$ 6,372 for stent retrievers per unit excluding taxes. Furthermore, other side effects of thrombectomy devices include bleeding from the area where the catheter is inserted, and appearance of bruise in the area causing pain. Moreover, with the breakdown of blood clots, chemicals are released, which can temporarily affect kidney function or rarely the heart.

Download PDF Brochure @

Key players operating in the global thrombectomy devices market include Applied Medical, Argon Medical Devices, Inc., Boston Scientific Corporation, BTG International, Capture Vascular, Claret Medical, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra, Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG, Stryker Corporation, Terumo Corporation, and Teleflex Incorporated.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.